tradingkey.logo
怜玢
マヌケット
ニュヌス
分析
ツヌル
株匏スクリヌナヌ


English
繁䜓䞭文
à¹„àž—àž¢
Tiếng việt
简䜓䞭文
Español
Português
Deutsch
한국얎
日本語

tradingkey.logo
怜玢



Roivant Sciences Ltd

ROIV
りォッチリストに远加
31.865USD
+0.435+1.38%
取匕時間 ET15分遅れの株䟡
22.61B時䟡総額
損倱額盎近12ヶ月PER

Roivant Sciences Ltd

31.865
+0.435+1.38%
抂芁
金融
ディスカッション
分析
䌁業名
プロフィヌル収益株䞻統蚈䌁業情報

抂芁

金融

ディスカッション

分析

䌁業名

プロフィヌル収益株䞻統蚈䌁業情報

株䞻

曎新時刻: Sun, May 10
曎新時刻: Sun, May 10
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Dexcel Pharma Technologies, Ltd.
14.37%
Fidelity Management & Research Company LLC
9.18%
Morgan Stanley Investment Management Inc. (US)
7.59%
BlackRock Institutional Trust Company, N.A.
5.19%
Ramaswamy (Vivek)
4.71%
他の
58.95%
株䞻統蚈
株䞻統蚈
比率
Dexcel Pharma Technologies, Ltd.
14.37%
Fidelity Management & Research Company LLC
9.18%
Morgan Stanley Investment Management Inc. (US)
7.59%
BlackRock Institutional Trust Company, N.A.
5.19%
Ramaswamy (Vivek)
4.71%
他の
58.95%
皮類
株䞻統蚈
比率
Investment Advisor
31.62%
Investment Advisor/Hedge Fund
18.77%
Corporation
14.37%
Hedge Fund
12.46%
Individual Investor
8.47%
Private Equity
4.86%
Research Firm
2.99%
Bank and Trust
0.83%
Sovereign Wealth Fund
0.73%
他の
4.90%

機関投資家保有株


曎新時刻: Wed, Apr 1
曎新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q1
781
565.52M
79.01%
-23.02M
2025Q4
728
545.59M
76.23%
-26.01M
2025Q3
690
526.70M
77.13%
-109.19M
2025Q2
673
776.63M
112.42%
-147.35M
2025Q1
676
776.88M
113.63%
-136.03M
2024Q4
645
780.70M
109.07%
-147.12M
2024Q3
601
789.51M
107.30%
-83.47M
2024Q2
564
721.13M
95.89%
-110.95M
2024Q1
518
776.24M
96.43%
-47.46M
2023Q4
449
787.20M
97.95%
-13.44M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Dexcel Pharma Technologies, Ltd.
102.85M
14.37%
--
--
Jul 01, 2025
Fidelity Management & Research Company LLC
65.72M
9.18%
+4.99M
+8.22%
Dec 31, 2025
Morgan Stanley Investment Management Inc. (US)
54.36M
7.59%
+13.70M
+33.71%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
37.13M
5.19%
+1.37M
+3.83%
Dec 31, 2025
Ramaswamy (Vivek)
33.71M
4.71%
-13.36M
-28.38%
Dec 31, 2025
QVT Financial LP
26.39M
3.69%
-1.69M
-6.03%
Dec 31, 2025
UBS Financial Services, Inc.
18.16M
2.54%
+16.01M
+745.83%
Dec 31, 2025
State Street Investment Management (US)
17.36M
2.43%
-1.34M
-7.16%
Dec 31, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
Invesco S&P MidCap 400 Pure Growth ETF
3.56%
Adaptiv Select ETF
2.91%
Virtus LifeSci Biotech Products ETF
2.79%
State Street SPDR S&P Biotech ETF
2.67%
WisdomTree US Value Fund
2.3%
ProShares Ultra Nasdaq Biotechnology
1.73%
Goldman Sachs Future Health Care Equity ETF
1.73%
Direxion Daily S&P Biotech Bull 3X Shares
1.41%
Invesco Nasdaq Biotechnology ETF
1.33%
WisdomTree BioRevolution Fund
1.3%
詳现を芋る
Invesco S&P MidCap 400 Pure Growth ETF
比率3.56%
Adaptiv Select ETF
比率2.91%
Virtus LifeSci Biotech Products ETF
比率2.79%
State Street SPDR S&P Biotech ETF
比率2.67%
WisdomTree US Value Fund
比率2.3%
ProShares Ultra Nasdaq Biotechnology
比率1.73%
Goldman Sachs Future Health Care Equity ETF
比率1.73%
Direxion Daily S&P Biotech Bull 3X Shares
比率1.41%
Invesco Nasdaq Biotechnology ETF
比率1.33%
WisdomTree BioRevolution Fund
比率1.3%
KeyAI
î™